Picture of Evaxion A/S logo

EVAX — Evaxion A/S News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Evaxion Announces Financing Commitments Totaling Up To USD 20 Million With Negma Group

Aug 1 (Reuters) - Evaxion Biotech A/S  EVAX.O :
    * EVAXION ANNOUNCES FINANCING COMMITMENTS TOTALING UP TO USD
20
MILLION WITH NEGMA GROUP
    * EVAXION BIOTECH A/S - FINANCING, AVAILABLE IN MULTIPLE
TRANCHES
OVER NEXT THREE YEARS, COULD EXTEND COMPANY'S RUNWAY INTO Q4
2024
    * EVAXION BIOTECH A/S - TRANSACTION WILL ENABLE EVAXION TO
ADVANCE
ITS NEXT-GENERATION CANCER VACCINE, EVX-03, TOWARDS A PHASE 1
CLINICAL TRIAL

Source text for Eikon:  ID:nGNX6wLJKv 
Further company coverage:  EVAX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Evaxion A/S

See all news